422 related articles for article (PubMed ID: 27004560)
21. Recent Advances in Pharmacotherapeutic Paradigm of Mild to Recalcitrant Atopic Dermatitis.
Hussain Z; Sahudin S; Thu HE; Shuid AN; Bukhari SN; Kumolosasi E
Crit Rev Ther Drug Carrier Syst; 2016; 33(3):213-263. PubMed ID: 27910751
[TBL] [Abstract][Full Text] [Related]
22. Topical calcineurin inhibitors in the treatment of atopic dermatitis - an update on safety issues.
Czarnecka-Operacz M; Jenerowicz D
J Dtsch Dermatol Ges; 2012 Mar; 10(3):167-72. PubMed ID: 21974750
[TBL] [Abstract][Full Text] [Related]
23. [Topical therapy for atopic eczema].
Knop M; Gürtler A; Heratizadeh A; Aszodi N; Werfel T; Wollenberg A
Hautarzt; 2018 Mar; 69(3):210-216. PubMed ID: 29487960
[TBL] [Abstract][Full Text] [Related]
24. Atopic dermatitis: an overview.
Berke R; Singh A; Guralnick M
Am Fam Physician; 2012 Jul; 86(1):35-42. PubMed ID: 22962911
[TBL] [Abstract][Full Text] [Related]
25. Comparative effectiveness of topical calcineurin inhibitors in adult patients with atopic dermatitis.
Frankel HC; Qureshi AA
Am J Clin Dermatol; 2012 Apr; 13(2):113-23. PubMed ID: 22263704
[TBL] [Abstract][Full Text] [Related]
26. Pimecrolimus: new preparation. Me-too: too many risks, not beneficial enough in atopic dermatitis.
Prescrire Int; 2004 Dec; 13(74):209-12. PubMed ID: 15599989
[TBL] [Abstract][Full Text] [Related]
27. Bilateral comparison study of pimecrolimus cream 1% and a ceramide-hyaluronic acid emollient foam in the treatment of patients with atopic dermatitis.
Frankel A; Sohn A; Patel RV; Lebwohl M
J Drugs Dermatol; 2011 Jun; 10(6):666-72. PubMed ID: 21637908
[TBL] [Abstract][Full Text] [Related]
28. Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis.
Hultsch T; Kapp A; Spergel J
Dermatology; 2005; 211(2):174-87. PubMed ID: 16088174
[TBL] [Abstract][Full Text] [Related]
29. Treatment of childhood eczema.
Granlund H
Paediatr Drugs; 2002; 4(11):729-35. PubMed ID: 12390044
[TBL] [Abstract][Full Text] [Related]
30. [Treatment of atopic dermatitis: practical approach].
Rossetti G; Laffitte E; Eigenmann PA; Lübbe J; Hohl D; Hofer MF
Rev Med Suisse; 2005 Feb; 1(7):501-4. PubMed ID: 15790018
[TBL] [Abstract][Full Text] [Related]
31. Phototherapy in Atopic Dermatitis.
Ortiz-Salvador JM; Pérez-Ferriols A
Adv Exp Med Biol; 2017; 996():279-286. PubMed ID: 29124708
[TBL] [Abstract][Full Text] [Related]
32. Topical tacrolimus in the management of atopic dermatitis in Japan.
Furue M; Uchi H; Moroi Y; Ogawa S; Nakahara T; Urabe K
Dermatol Ther; 2006; 19(2):118-26. PubMed ID: 16669995
[TBL] [Abstract][Full Text] [Related]
33. [Atopic dermatitis - current insights into path physiology and management].
Schmid-Grendelmeier P; Ballmer-Weber BK
Ther Umsch; 2010 Apr; 67(4):175-85. PubMed ID: 20336617
[TBL] [Abstract][Full Text] [Related]
34. [Safety of topical tacrolimus and pimecrolimus in children with atopic dermatitis].
Rodríguez Orozco AR; Ruiz Reyes H; Marín Hernández D
Rev Alerg Mex; 2005; 52(4):171-6. PubMed ID: 16268186
[TBL] [Abstract][Full Text] [Related]
35. Topical calcineurin inhibitors for the treatment of vulvar dermatoses.
Goldstein AT; Thaçi D; Luger T
Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):22-9. PubMed ID: 19631446
[TBL] [Abstract][Full Text] [Related]
36. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
[TBL] [Abstract][Full Text] [Related]
37. Phototherapy for atopic dermatitis.
Dogra S; Mahajan R;
Indian J Dermatol Venereol Leprol; 2015; 81(1):10-5. PubMed ID: 25566890
[TBL] [Abstract][Full Text] [Related]
38. The topical calcineurin inhibitor pimecrolimus in atopic dermatitis: a safety update.
Thaçi D; Salgo R
Acta Dermatovenerol Alp Pannonica Adriat; 2007 Jun; 16(2):58, 60-62. PubMed ID: 17992459
[TBL] [Abstract][Full Text] [Related]
39. What's new in atopic eczema? An analysis of the clinical significance of systematic reviews on atopic eczema published in 2006 and 2007.
Williams HC; Grindlay DJ
Clin Exp Dermatol; 2008 Nov; 33(6):685-8. PubMed ID: 18691244
[TBL] [Abstract][Full Text] [Related]
40. Long-term management of facial atopic eczema with pimecrolimus cream 1% in paediatric patients with mild to moderate disease.
Zuberbier T; Bräutigam M
J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):718-21. PubMed ID: 18312323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
